News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts

Spotlight -

Downstream Processing|

Upstream Processing

Atul Khandekar

Atul Khandekar is COO of SymphonyTech Biologics

Articles by Atul Khandekar

A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19

BySmritie Sheth,Ravindra Khare,Atul Khandekar,Guljit Chaudhuri,Shilpa Jindani,Narendra Chirmule,Brinda Kakkar,Raman Govindrajan,Smita Kale,V. Premnath,Ranganayaki Nagaraj

February 2nd 2021

A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis

Latest Updated Articles

A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19
February 2nd 2021